DAI
Global, LLC seeks an Evidence Utilization Specialist for
USAID’s Flagship Maternal and Child Health Program, based in Jakarta,
Indonesia. The Flagship Maternal and Newborn Health (MNH) Activity promotes the
development of locally led solutions to prevent maternal and newborn deaths and
extend essential health services to remote and impoverished areas.
The Evidence
Utilization Specialist will work to ensure a seamless progression from the
generation of evidence through research to the use of evidence to strengthen
national MNH policies and programs. The EU Specialist will also work in concert
with the MERL Director to ensure that this evidence is available and used at
the global level to promote global policy and standards development.
Specific
responsibilities include:
·
Oversee
technical quality and lead field-level implementation of activities related to
evidence utilization.
·
Provide
targeted assistance to field staff, partners, and grantees to ensure that they
have access to data, and to build their capacity in using that data for
decision making
·
Contribute
to the identification and development of country-level activities to ensure that
an explicit RU strategy is included in the design, implementation, and
evaluation of all research projects
Qualifications:
·
Minimum
of 7 years of experience working within Indonesia’s health system with
expertise in evidence utilization/data for decision making.
·
Master’s
degree in a relevant field required; PhD preferred.
·
Demonstrated
excellence in writing and editing in English.
·
Previous
exposure and experience in developing, implementing, and monitoring
dissemination plans for knowledge products highly preferred.
·
Experience
working with government, NGOs, donors, and other relevant stakeholders
·
Ability
to work in complex environments with multiple tasks, competing priorities, and
short deadlines.
Interested
and qualified applicants should send their CV and cover letter to indonesiamnh@dai.com, not later than November 20, 2017. Please stated “Technical
Specialist- Evidence Utilization” in the subject line.

No comments:
Post a Comment